Array BioPharma, Inc. (NASDAQ:ARRY)
CAPS Rating:
A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.
RSS Headlines
Fool UK
Recs
Good pipeline. Market is overrating the risk.